Basic Information
PEEL Therapeutics is an emerging biotechnology company established in the United States and Israel, dedicated to developing evolution-based drugs to help patients around the world. PEEL Therapeutics' R&D pipeline originates from assets inspired by the evolution of elephants, plants, and humans, for the treatment of cancer and various inflammatory diseases.
Peel Therapeutics, Inc.
SaltLakeCity,Utah,United States of America
less than 15 people
January 01, 2015
--

